Morinaga Milk Industry Co., Ltd. Patent applications |
Patent application number | Title | Published |
20160115047 | POWER CONTROL DEVICE AND CONTROL METHOD FOR POWER CONTROL DEVICE - A power control device supplies electrolysis voltage and electrolysis current, based on input direct-current power, to an electrolytic cell for manufacturing electrolysis water by electrolysis on a raw material solution by means of electric current applied between an anode and a cathode. The power control device includes: a voltage-current control circuit that, in a constant current control mode, supplies the electrolysis current to the electrolytic cell while the voltage-current control circuit controls the electrolysis current not to exceed a current value of a reference current, the current value of the reference current being preliminarily set according to a rated current of unit cells constituting the electrolytic cell, the voltage-current control circuit, in a constant voltage control mode, supplying the electrolysis voltage to the electrolytic cell while the voltage-current control circuit controls the electrolysis voltage not to exceed a voltage value of a reference voltage, the voltage value of the reference voltage being preliminarily set according to a rated voltage and the number of the unit cells constituting the electrolytic cell. The voltage-current control circuit switches between the constant current control mode and the constant voltage control mode, according to a concentration of electrolyte solution within the electrolytic cell. | 04-28-2016 |
20160114024 | LACTIC ACID BACTERIUM, DRUG, FOOD OR DRINK, AND FEED WHICH CONTAIN THE LACTIC ACID BACTERIUM | 04-28-2016 |
20150328182 | IGF-1 PRODUCTION-PROMOTING AGENT - An extract of | 11-19-2015 |
20150289532 | METHOD FOR PRODUCING PROCESSED CHEESE - A processed cheese is produced by producing a natural cheese (N) via an acidification step, a coagulation step and a dehydration step described below, and then using the obtained natural cheese (N) for at least 5% by mass of an ingredient cheese. The acidification step is a step of acidifying a milk to obtain an acidified milk having a pH of 5.8 to 6.4, in which an acid component is added to the milk to achieve the required pH for the acidified milk, the coagulation step is a step of obtaining a curd by adding a milk coagulating enzyme to the acidified milk to cause coagulation, without adding a lactic acid bacterium starter, and the dehydration step is a step of obtaining the natural cheese (N) by separating whey from the curd, and includes an enzyme inactivation step of inactivating the milk coagulating enzyme by cooking the curd to at least 55° C. at a rate of temperature increase of not more than 1° C. per minute. | 10-15-2015 |
20150259223 | ELECTROLYZED WATER PRODUCTION DEVICE, ELECTROLYZED WATER PRODUCTION METHOD, AND ELECTROLYTIC BATH - This electrolyzed water production device ( | 09-17-2015 |
20150250184 | ANTIMICROBIAL ACTIVITY ENHANCING AGENT - An antimicrobial activity enhancing agent for lactoferrin or a lactoferrin hydrolysate, which contains ribonuclease-4 as an active ingredient, and a method for producing an antimicrobial activity enhancing agent for lactoferrin or a lactoferrin hydrolysate, which comprises (a) the step of contacting raw milk with a cation exchange resin to adsorb proteins in the raw milk to the cation exchange resin, (b) the step of washing the cation exchange resin having undergone the adsorption treatment, and flowing an elution solvent to elute a protein fraction having an isoelectric point of 8.0 to 10.0, and (c) the step of subjecting the eluted protein fraction to gel filtration using a gel filtration carrier to collect a fraction of a molecular weight of 30 kDa or less. | 09-10-2015 |
20150232510 | DIPEPTIDYL PEPTIDASE-IV INHIBITOR - An excellent peptidyl peptidase-IV inhibitor and the like are provided. A peptide consisting of Val-Pro-X wherein X represents an amino acid residue (except for L-proline residue); the aforementioned X is preferably one selected from a basic amino acid residue, an aliphatic neutral amino acid residue, an amide group-carrying neutral amino acid residue, or an aromatic group-carrying neutral amino acid residue; the aforementioned X is preferably one selected from an alanine residue, a glutamine residue, a methionine residue, an asparagine residue, a glycine residue, a valine residue, a tyrosine residue, a serine residue, and a lysine residue; a dipeptidyl peptidase-IV inhibitor, a blood sugar rise suppressing agent, a vascular endothelial disorder suppressing agent, and an angiotensin converting enzyme inhibitor containing the aforementioned peptide as an active ingredient. | 08-20-2015 |
20150139955 | AGENT FOR PROMOTING PROLIFERATION OF BIFIDOBACTERIA - A peptide dimer comprising a peptide consisting of the amino acid sequence of SEQ ID NO: 1 and a peptide consisting of any one of the amino acid sequences of SEQ ID NOS: 2 to 4, wherein the peptide consisting of the amino acid sequence of SEQ ID NO: 1 and the peptide consisting of any one of the amino acid sequences of SEQ ID NOS: 2 to 4 are bound through a disulfide bond between a cysteine residue of each peptide is used as an active ingredient of an agent for promoting proliferation of one or more bacterium selected from the group consisting of | 05-21-2015 |
20140216926 | ELECTROLYSIS WATER-MAKING APPARATUS - The electrolysis water-making apparatus (A) which is an apparatus for making electrolysis water (W | 08-07-2014 |
20140190821 | ELECTROLYSIS WATER-MAKING APPARATUS - The electrolysis water-making apparatus (A) includes: an electrolytic cell ( | 07-10-2014 |
20140134704 | Antimicrobial Activity Enhancing Agent - An antimicrobial activity enhancing agent for lactoferrin or a lactoferrin hydrolysate, which contains ribonuclease-4 as an active ingredient, and a method for producing an antimicrobial activity enhancing agent for lactoferrin or a lactoferrin hydrolysate, which comprises (a) the step of contacting raw milk with a cation exchange resin to adsorb proteins in the raw milk to the cation exchange resin, (b) the step of washing the cation exchange resin having undergone the adsorption treatment, and flowing an elution solvent to elute a protein fraction having an isoelectric point of 8.0 to 10.0, and (c) the step of subjecting the eluted protein fraction to gel filtration using a gel filtration carrier to collect a fraction of a molecular weight of 30 kDa or less. | 05-15-2014 |
20140086959 | METHOD FOR PRODUCING MILK HAVING AN IMMUNOREGULATORY ACTION - A method for screening for a foodstuff providing production of milk having an immunoregulatory action, a foodstuff having an immunoregulatory action, and a method for producing it are provided. A diet or substance that increases or decreases an amount of microRNA present in milk of a mammal is identified by using correlation of microRNA profiles in the milk and a diet ingested by the mammal or a substance contained in the diet as an index to screen for a diet or a substance providing production of breast milk having an immunoregulatory action. | 03-27-2014 |
20140021040 | BIPOLAR-ELECTRODE ELECTROLYTIC CELL - The invention is a bipolar-electrode electrolytic cell ( | 01-23-2014 |
20140008263 | PACKAGING MATERIAL AND PACKED PRODUCT IN WHICH VISCOUS PRODUCT IS PACKED BY PACKAGING MATERIAL - A packaging material | 01-09-2014 |
20130280368 | METHOD FOR SCREENING FOR DIET PROVIDING PRODUCTION OF MILK HAVING IMMUNOREGULATORY ACTION - A diet or a substance providing production of breast milk having an immunoregulatory action is screened for by identifying a diet or a substance that increases or decreases amount of mRNA present in milk of a mammal using correlation of mRNA profile in the milk and a diet ingested by the mammal or a substance contained in the diet as an index. | 10-24-2013 |
20130189396 | METHOD FOR PRODUCING A FERMENTED FOOD CONTAINING BIFIDOBACTERIA - A milk raw material is fermented by using | 07-25-2013 |
20130146449 | Electrolysis Water-Making Apparatus - An electrolysis water-making apparatus ( | 06-13-2013 |
20130129707 | ANTIMICROBIAL ACTIVITY ENHANCING AGENT - An antimicrobial activity enhancing agent for lactoferrin or a lactoferrin hydrolysate, which contains a milk protein as an active ingredient and has the following properties, and a method for producing the antimicrobial activity enhancing agent, which comprises (a) the step of contacting raw milk with a cation exchange resin to adsorb proteins in the raw milk to the cation exchange resin, (b) the step of washing the cation exchange resin having undergone the adsorption treatment, and flowing an elution solvent to elute a protein fraction having an isoelectric point of 9.0 to 11.0, and (c) the step of subjecting the eluted protein fraction to membrane filtration using an ultrafiltration membrane having a molecular weight cutoff of 30 kDa to prepare the milk protein having the following properties: | 05-23-2013 |
20130079314 | ALOE VERA EXTRACT, METHOD OF PRODUCING ALOE VERA EXTRACT, AND HYPERGLYCEMIA IMPROVING AGENT - The present invention provides: an | 03-28-2013 |
20130068612 | Electrolysis Water-Making Apparatus - An electrolysis water-making apparatus ( | 03-21-2013 |
20120322726 | THERAPEUTIC AGENT FOR EATING DISORDERS - Disclosed is a highly safe and effective therapeutic agent for eating disorders, which contains, as an active ingredient, a water-soluble fraction of a hydrolysis product of casein. The hydrolysis product is obtained by means of pepsin. | 12-20-2012 |
20120315261 | ANTIBACTERIAL AUXILIARY AGENT COMPRISING KOMBU EXTRACT AS ACTIVE INGREDIENT, ANTIBACTERIAL COMPOSITION, AND FOOD OR BEVERAGE - Disclosed are: a method for utilizing a kombu (kelp) extract as an antibacterial auxiliary agent; and a method for utilizing a combination of the antibacterial auxiliary agent, lactoperoxidase, glucose oxidase and glucose as an antibacterial composition having a potent antibacterial activity. Specifically disclosed are: an antibacterial auxiliary agent comprising a fraction having a molecular weight of 5000 or less and produced from a kombu extract as an active ingredient; an antibacterial composition comprising the antibacterial auxiliary agent, lactoperoxidase, glucose oxidase and glucose; an antibacterial composition as mentioned above, which additionally comprises xanthane gum; and a food or beverage containing the antibacterial composition. | 12-13-2012 |
20120309708 | METHOD FOR TREATMENT OF LACTO-N-BIOSE-CONTAINING SOLUTION - The present invention relates to a method of treating a liquid composition containing lacto-N-biose, the method including: preparing a liquid composition containing lacto-N-biose having a pH at 25° C. of not less than 2.0 and not more than 5.5, and heating the liquid composition at a temperature of 65° C. or higher. The present invention can provide a treatment method that enables thermal decomposition of lacto-N-biose to be suppressed when a liquid composition containing lacto-N-biose is heated at a temperature of 65° C. or higher, a liquid preparation containing lacto-N-biose that is treated using the treatment method, a dried product produced from such a liquid preparation containing lacto-N-biose, and a method of producing a product containing lacto-N-biose. | 12-06-2012 |
20120277121 | KIT FOR DETECTION OF MICROORGANISM - A kit for use in a method for detecting live cells, injured cells and dead cells of a microorganism in a test sample by a nucleic acid amplification method is disclosed. The kit includes a cross-linker capable of cross-linking DNA by irradiation with light having a wavelength of 350 nm to 700 nm, medium, and a primer (s) for amplifying a DNA target region in the microorganism by a nucleic acid amplification method. The nucleic acid amplification method may be a PCR, LAMP, SDA, LCR or DNA microarray method. A cross-linker may be included in the kit such as ethidium monoazide, ethidium diazide, psoralen, 4,5′,8-trimethyl psoralen, or 8-methoxy psoralen. | 11-01-2012 |
20120263839 | METHOD FOR MANUFACTURING LOW-PHOSPHORUS WHEY - A method of manufacturing a low-phosphorus whey, the method including subjecting a raw whey liquid to a demineralization treatment using a nanofiltration method to obtain a low-chloride whey liquid in which the chloride content has been reduced to not more than 30 mmol per 100 g of solids, and passing the low-chloride whey liquid through an ion exchange resin to obtain an ion-exchanged whey liquid having a reduced phosphorus content, wherein the ion exchange resin is composed of an anion exchange resin, and at least an anion exchange resin in chloride form is used as the anion exchange resin. The method of manufacturing a low-phosphorus whey can reduce the phosphorus content within the whey while suppressing reduction in the calcium and magnesium content. | 10-18-2012 |
20120244571 | MEASUREMENT METHOD FOR VIABLE CELL COUNT, AND CULTURE MEDIUM - There are provided a method of identifying a microorganism belonging to | 09-27-2012 |
20120183665 | CHEESE-CONTAINING FOOD AND METHOD FOR PRODUCING SAME - A method for producing a cheese-containing food, the method including a step (1) of heating a soft cheese-containing mixture that contains 70 to 100% by mass of a soft cheese using a Joule heater, and a step (2) of stirring the heated soft cheese-containing mixture under shearing in a high speed shear cooker, wherein the series of steps including the steps (1) and (2) is performed at least twice. With this method, a cheese-containing food having satisfactory quality in terms of smoothness in the mouth and flavor and the like can be produced by using a raw material having a high soft cheese content. | 07-19-2012 |
20120177624 | ORAL DISINFECTANT, AND FOOD ADDITIVE COMPRISING THE DISINFECTANT - Disclosed is a disinfectant which is safe, has few adverse side-effects, can be ingested together with a food or beverage by adding the disinfectant to the food or beverage, shows a bactericidal effect in the oral cavity, and has no problem even when ingested on a daily basis over a long period. Also disclosed is a food additive comprising the disinfectant. Specifically, disclosed is an oral disinfectant for the disinfection of an oral bacterium, which comprises lactoperoxidase, glucose oxidase, glucose and a pH-adjusting component. | 07-12-2012 |
20120171167 | ANTI-OBESITY AGENT, ANTI-OBESITY FOOD OR BEVERAGE, GLUCOSE TOLERANCE-AMELIORATING AGENT, AND FOOD OR BEVERAGE FOR AMELIORATION OF GLUCOSE TOLERANCE - An anti-obesity agent or a glucose tolerance-ameliorating agent containing a bacterium belonging to the genus | 07-05-2012 |
20120149054 | MEASUREMENT METHOD FOR VIABLE CELL COUNT, AND CULTURE MEDIUM - There are provided a method of identifying the | 06-14-2012 |
20120122082 | METHOD AND KIT FOR DETECTION OF MICROORGANISM - Live cells of microorganism in a test sample are detected by distinguishing the live cells from dead cells or injured cells by the following steps of:
| 05-17-2012 |
20120108508 | METHOD FOR PROMOTING SECRETION OF GLUCAGON-LIKE PEPTIDE-1 BY ADMINISTERING K-CASEIN - The invention relates to a GLP-1 secretagogue and an inhibitor of postprandial rise in blood glucose, containing κ-casein as an active ingredient, and a food or drink for promoting GLP-1 secretion and an inhibitory food or drink of postprandial rise in blood glucose, containing a milk-derived casein protein wherein κ-casein accounts for 60% by mass or more of the milk-derived casein. | 05-03-2012 |
20120093874 | METHOD FOR SCREENING FOR DIET PROVIDING PRODUCTION OF MILK HAVING IMMUNOREGULATORY ACTION - A method for screening for a foodstuff providing production of milk having an immunoregulatory action, a novel foodstuff having an immunoregulatory action, and a method for producing it are provided. A diet or substance that increases or decreases an amount of microRNA present in milk of a mammal is identified by using correlation of microRNA profiles in the milk and a diet ingested by the mammal or a substance contained in the diet as an index to screen for a diet or a substance providing production of breast milk having an immunoregulatory action. | 04-19-2012 |
20110293202 | SPOUT MEMBER AND PACKAGING BAG UTILIZING SAME - It is aimed to provide a spout member and a packaging bag using the spout member which have excellent handling property and hygiene management performance at the time of supplying water or the like from the outside before and during use such as administration of water and medicine, in which a closure means for freely opening and closing an aperture formed by cutting off parts of peripheral portions of sealed film pieces is protected from a contained content at the time of storage or transportation and which have excellent protecting property even when an inner pressure acts in the packaging bag, excellent contamination preventing property until a spout is opened and excellent contamination preventing property and handling property after opening. | 12-01-2011 |
20110262421 | PHARMACEUTICAL COMPOSITION, FOOD OR DRINK, OR FEED FOR INTESTINAL DISEASE - It is intended to provide a pharmaceutical composition, a food or drink, or a feed which has an effect on the prevention and/or treatment of an intestinal disease such as ulcerative colitis, Crohn's disease or irritable bowel syndrome. A preferred embodiment is the pharmaceutical composition, food or drink, or feed which contains lactoperoxidase as an active ingredient and has an effect on the prevention and/or treatment of an intestinal disease, wherein the intestinal disease is at least one disease selected from ulcerative colitis, Crohn's disease and irritable bowel syndrome. | 10-27-2011 |
20110233212 | Packaging Material and Packed Product in which Viscous Product is Packed by Packaging Material - A packaging material | 09-29-2011 |
20110212931 | ANTIOXIDANT - Provided is an antioxidant which is highly safe, inhibits oxidation of a biological component, in particular, a lipid, and may be used as a drug, food or drink, a food additive, an external preparation for skin, or the like. The antioxidant contains a compound selected from a cyclolanostane compound and a lophenol compound as an active ingredient. | 09-01-2011 |
20110112813 | METHOD FOR ESTIMATING SURVIVAL CELL COUNT, AND METHOD FOR SETTING GUARANTEED CELL COUNT - The present invention provides a method for estimating survival cell count, which is able to calculate an accurately estimated result of the survival cell count of a specific strain in a probiotic product with respect to its storage period, and to shorten the time for developing the product, and a method for setting a guaranteed cell count, which is able to readily calculate a guaranteed cell count of a specific strain in a probiotic product within its quality guarantee period. The method for estimating the survival cell count is characterized by estimating the survival cell count n | 05-12-2011 |
20110104746 | Diluting Solution For Suspension For Use In The Measurement Of Number Of Living Microbial Cells Contained In Sample, And Method For Measurement Of Number Of Living Microbial Cells - A dilution buffer for suspension and an enumeration method, which, for the measurement of the viable cell count of a microorganism contained within a sample, and particularly a powdered product such as a milk powder, yield more accurate measurement values than have conventionally been obtainable. A dilution buffer for suspension, used for preparing a suspension buffer of a sample when conducting a measurement of the viable cell count of a microorganism contained within the sample, wherein the dilution buffer contains polysorbates at a concentration of not less than 0.5%. Also, an enumeration method for a microorganism contained within a sample, the method including: preparing a suspension buffer of the sample using a dilution buffer for suspension containing polysorbates at a concentration of not less than 0.5%, and measuring the viable cell count of the microorganism contained within the suspension buffer. | 05-05-2011 |
20110104314 | ALOE VERA EXTRACT, METHOD OF PRODUCING ALOE VERA EXTRACT, AND HYPERGLYCEMIA IMPROVING AGENT - The present invention provides: an | 05-05-2011 |
20110071768 | DEVICE FOR ESTIMATING SURVIVAL CELL COUNT, COMPUTER PROGRAM, AND RECORDING MEDIUM - By accurately estimating the survival cell count in a probiotic product, the time for developing the product can be shortened. In a device ( | 03-24-2011 |
20110053790 | METHOD AND KIT FOR DETECTION OF MICROORGANISM - A live cell of microorganism in a test sample is detected by the following steps of: a) adding a cross-linker capable of cross-linking a DNA by irradiation with light having a wavelength of 350 nm to 700 nm to the test sample; b) irradiating the test sample to which the cross-linker is added with light having a wavelength of 350 nm to 700 nm; c) removing the cross-linker contained in the test sample irradiated with light; d) adding a medium to the test sample from which the cross-linker is removed and incubating the test sample; e) adding again the cross-linker capable of cross-linking a DNA by irradiation with light having a wavelength of 350 nm to 700 nm to the incubated test sample; f) irradiating the test sample to which the cross-linker is added with light having a wavelength of 350 nm to 700 nm; g) extracting a DNA from the test sample and amplifying a target region of the extracted DNA by a nucleic acid amplification method; and h) analyzing the amplified product. | 03-03-2011 |
20110020821 | METHOD FOR DETECTION OF MICROORGANISM AND KIT FOR DETECTION OF MICROORGANISM - According to the following steps, live cells, injured cells, VNC cells and dead cells of a microorganism in a test sample are detected by flow cytometry:
| 01-27-2011 |
20110020820 | METHOD FOR DETECTION OF MICROORGANISM AND KIT FOR DETECTION OF MICROORGANISM - A kit is disclosed for preparing a measurement sample for detecting live cells, injured cells, VNC cells and dead microorganism cells in a test sample by the following steps:
| 01-27-2011 |
20110003975 | METHOD OF DENATURING WHEY PROTEIN - Provided is a method of producing a denatured whey protein which has an improved heat stability without using an additive such as an organic solvent. Also provided is a denatured whey protein produced by this method. A method of producing a denatured whey protein which comprises contacting and mixing a whey protein solution with a whey protein solution that is flowing as a thin film in the form of a rotating cylinder, and thus shearing the same at a temperature ranging form 76 to 120° C. at a shear speed of 5,000 s | 01-06-2011 |
20100310673 | SUBSTANCE AND COMPOSITION BOTH CAPABLE OF IMPARTING HEAT RESISTANCE - An agent for thermally stabilizing lactoferrin, which comprises a nucleic acid as an active ingredient, can be added to lactoferrin to impart thermal stability to lactoferrin. Thermally stabilized lactoferrin can be heat-sterilized at a pH value around a neutral pH value while keeping its activity. | 12-09-2010 |
20100286104 | AGENT FOR INHIBITING VISCERAL FAT ACCUMULATION - To reduce amounts of fat accumulated in abdominal cavity and to prevent or ameliorate visceral fat type obesity, considered to be a main factor of metabolic syndrome, the present invention provides an agent or a food or drink which contains a compound having a lophenol skeleton, or an organic solvent extract or a hot water extract of a Liliaceae plant, or a fraction thereof containing the compound as an active ingredient. | 11-11-2010 |
20100266725 | Method For Producing Fermented Milk - The present invention provides a method for producing fermented milk, the method employing a lactic acid bacterium capable of improving proliferative properties of | 10-21-2010 |
20100247711 | Acidic Lactic Acid Bacteria Beverage And Method Of Producing Acidic Lactic Acid Bacteria Beverage - An acidic lactic acid bacteria beverage having a favorable flavor and an improved survival rate for bifidobacteria. The acidic lactic acid bacteria beverage of the present invention includes bifidobacteria and inulin, wherein the inulin is not fermented by the bifidobacteria. The inulin content is preferably within a range from 1 to 10% by mass, and the pH of the acidic lactic acid bacteria beverage is preferably within a range from 4.1 to 4.8. | 09-30-2010 |
20100240632 | DRUG FOR IMPROVING HYPERGLYCEMIA - A compound having a hyperglycemia improving effect and a hemoglobin A1c lowering action such as 4-methylcholest-7-en-3-ol, 4-methylergost-7-en-3-ol and 4-methylstigmast-7-en-3-ol is used as an active ingredient of a drug or food or drink for improving hyperglycemia. | 09-23-2010 |
20100221745 | ABNORMAL PRION PROTEIN BINDER, AND METHOD FOR DETECTION OF ABNORMAL PRION PROTEIN - Disclosed are: a method for detecting pathogenic isoform of prion protein as distinguished from normal prion protein in a simple manner, rapidly, with a high degree of sensitivity and quantitatively without the need of the enzymatic treatment with protease K; and a reagent for use in the method. Specifically disclosed are: a pathogenic isoform of prion protein binder which comprises lactoferrin; and a method for detecting pathogenic isoform of prion protein by using the pathogenic isoform of prion protein binder. | 09-02-2010 |
20100170777 | AGENT FOR DEGRADING A NUCLEIC ACID AND METHOD OF DEGRADING A NUCLEIC ACID - The present invention provides an agent for degrading a nucleic acid, which includes ethidium monoazide as an active ingredient, and is useful as an antibacterial agent such as a bactericide or a disinfectant. | 07-08-2010 |
20100144638 | GLUCAGON-LIKE PEPTIDE-1 SECRETAGOGUE, GLUCAGON-LIKE PEPTIDE-1 SECRETAGOGUE FOOD OR DRINK, INHIBITOR OF POSTPRANDIAL RISE IN BLOOD GLUCOSE, AND INHIBITORY FOOD OR DRINK OF POSTPRANDIAL RISE IN BLOOD GLUCOSE - The invention relates to a GLP-1 secretagogue and an inhibitor of postprandial rise in blood glucose, containing κ-casein as an active ingredient, and a food or drink for promoting GLP-1 secretion and an inhibitory food or drink of postprandial rise in blood glucose, containing a milk-derived casein protein wherein κ-casein accounts for 60% by mass or more of the milk-derived casein. | 06-10-2010 |
20100086988 | NOVEL LACTIC ACID BACTERIA - The present invention relates to bacteria of a genus | 04-08-2010 |
20100055288 | Continuous Emulsification Process for Process Cheese Type and Equipment Therefor, and Continuous Production Method for Process Cheese Type and Equipment Therefor - Objects of the present invention are to provide a continuous emulsification process and equipment therefor in which exact viscosity is measured inline and production conditions are controlled automatically, and a continuous production method for process cheese type and equipment therefor. The present invention provides a continuous production method for process cheese type in which process cheese type ingredients are agitated and emulsified with any agitation intensity by an agitation bar | 03-04-2010 |
20100043574 | Test Vessel, Test Strip, Test Kit, And Test Method - The present invention relates to a test vessel used in a test method having a step of immersing one end ( | 02-25-2010 |
20100035851 | AGENT FOR IMPROVING INSULIN RESISTANCE - To inhibit production of adipocytokines, in particular, adipocytokines that elicit insulin resistance and to prevent onset of pathosis caused by the insulin resistance, or improve the pathosis, the present invention provides an agent or a food or drink which contains a compound having a cyclolanostane skeleton, or an organic solvent extract, a hot water extract of a plant of the family Liliaceae or Gramineae, or a fraction thereof which contains the compound as an active ingredient. | 02-11-2010 |
20100028274 | ORAL DISINFECTANT, AND FOOD ADDITIVE COMPRISING THE DISINFECTANT - Disclosed is a disinfectant which is safe, has few adverse side-effects, can be ingested together with a food or beverage by adding the disinfectant to the food or beverage, shows a bactericidal effect in the oral cavity, and has no problem even when ingested on a daily basis over a long period. Also disclosed is a food additive comprising the disinfectant. Specifically, disclosed is an oral disinfectant for the disinfection of an oral bacterium, which comprises lactoperoxidase, glucose oxidase, glucose and a pH-adjusting component. | 02-04-2010 |
20090312275 | AGENT FOR IMPROVING INSULIN RESISTANCE - To inhibit production of adipocytokines, in particular, adipocytokines that elicit insulin resistance and to prevent onset of pathosis caused by the insulin resistance, or improve the pathosis, the present invention provides an agent or a food or drink which contains 3-O-β-D-glucopyranosyl-4-methylergost-7-en-3-ol, or an organic solvent extract, a hot water extract or a squeezed liquid of a plant of the family Liliaceae or a fraction thereof which contains the compound as an active ingredient. | 12-17-2009 |
20090305240 | METHOD FOR DETECTION OF MICROORGANISM AND KIT FOR DETECTION OF MICROORGANISM - Live cells of a microorganism in a test sample are detected by the following steps:
| 12-10-2009 |
20090194893 | Chewable Capsule and Production Method Thereof - This chewable capsule has an encapsulating shell and a filling contained within the encapsulating shell, in which outer diameter of the above encapsulating shell ranges from 14 mm to 25 mm, and mass of the above encapsulating shell, ranges from 10% to 20% of the total mass of the chewable capsule, the quantity of the above filling contained within the above encapsulating shell ranges from 1400 mg to 3000 mg, and gelatin is contained in the above encapsulating shell. | 08-06-2009 |
20090170772 | INTERLEUKIN PRODUCTION REGULATOR, PHARMACEUTICAL COMPOSITION OR FOOD COMPRISING THE INTERLEUKIN PRODUCTION REGULATOR, AND METHOD FOR PRODUCTION OF THE INTERLEUKIN PRODUCTION REGULATOR - An object is to provide an interleukin production regulator which can be used for prevention, treatment or recurrence prevention of a gastrointestinal disease or an autoimmune disease accompanied by an inflammation as the main symptom, which is highly safe, and which can be administered over a long period. Another object is to provide a method for production of the interleukin production regulator. Further object is to provide a pharmaceutical composition and a food, each of which comprises the interleukin production regulator. | 07-02-2009 |
20090136634 | SEASONED TOFU AND METHOD OF PRODUCING THE SAME - It is intended to provide seasoned tofu which has a favorable mouthfeel in “hardness” and “brittleness” and has been evenly seasoned throughout, and a method of producing the same. Seasoned tofu is produced by heating and coagulating seasoned soymilk containing soybean milk, a seasoning providing sodium ion and/or potassium ion and glucono delta-lactone as a coagulant wherein the concentration of soybean protein is 5.5% by mass or more and 8.5% by mass or less, the total concentration of the sodium ion and/or potassium ion is 0.05 mol/L or more and 0.154 mol/L or less and the concentration of the glucono delta-lactone is 0.4% by mass or more and 0.9% by mass or less. | 05-28-2009 |
20090131388 | Agent for Improving Insulin Resistance - To inhibit production of adipocytokines, in particular, adipocytokines that elicit insulin resistance and to prevent onset of pathosis caused by the insulin resistance or ameliorate the pathosis, the present invention provides an agent or a food or drink which contains a compound having a lophenol skeleton, or an organic solvent extract or a hot water extract of a Liliaceae plant or, a fraction thereof containing the compound as an active ingredient. | 05-21-2009 |
20090131316 | GLUCAGON-LIKE PEPTIDE-1 SECRETAGOGUE, GLUCAGON-LIKE PEPTIDE-1 SECRETAGOGUE FOOD OR DRINK, INHIBITOR OF POSTPRANDIAL RISE IN BLOOD GLUCOSE, AND INHIBITORY FOOD OR DRINK OF POSTPRANDIAL RISE IN BLOOD GLUCOSE - The invention relates to a GLP-1 secretagogue and an inhibitor of postprandial rise in blood glucose, containing κ-casein as an active ingredient, and a food or drink for promoting GLP-1 secretion and an inhibitory food or drink of postprandial rise in blood glucose, containing a milk-derived casein protein wherein κ-casein accounts for 60% by mass or more of the milk-derived casein. | 05-21-2009 |
20090093450 | AGENT FOR INHIBITING VISCERAL FAT ACCUMULATION - To reduce amounts of fat accumulated in abdominal cavity and to prevent or ameliorate visceral fat type obesity, considered to be a main factor of metabolic syndrome, the present invention provides an agent or a food or drink which contains a compound having a lophenol skeleton, or an organic solvent extract or a hot water extract of a Liliaceae plant, or a fraction thereof containing the compound is used as an active ingredient. | 04-09-2009 |
20090093008 | METHOD FOR DETECTION OF MICROORGANISM AND KIT FOR DETECTION OF MICROORGANISM - According to the following steps, live cells, injured cells, VNC cells and dead cells of a microorganism in a test sample are detected by flow cytometry: | 04-09-2009 |
20090075913 | GLYCOSIDE HAVING 4-METHYLERGOST-7-EN-3-OL SKELETON AND HYPERGLYCEMIA IMPROVING AGENT - 3-O-β-D-Glucopyranosyl-4-methylergost-7-en-3-ol or a composition containing 0.001% by mass or more of the aforementioned compound, which is an extract of a plant of the family Liliaceae containing the compound or a fraction thereof, is used as an active ingredient of a hyperglycemia improving agent. | 03-19-2009 |
20090069254 | AGENT FOR INHIBITING VISCERAL FAT ACCUMULATION - To reduce amounts of fat accumulated in abdominal cavity and to prevent or ameliorate visceral fat type obesity considered to be a main factor of metabolic syndrome, there is provided an agent or a food or drink, including as an active ingredient 3-O-β-D-glucopyranosyl-4-methylergost-7-en-3-ol, an organic solvent extract, a hot water extract, a squeezed liquid of a Liliaceae plant or a fraction thereof which contains the compound. | 03-12-2009 |
20090035416 | METHOD FOR PRODUCING FERMENTED MILK USING NOVEL LACTIC ACID BACTERIA - The present invention relates to a method for producing a fermented milk, including: performing fermentation using both bacteria belonging to the genus | 02-05-2009 |
20090017100 | PHARMACEUTICAL COMPOSITION, FOOD OR DRINK, OR FEED FOR INTESTINAL DISEASE - It is intended to provide a pharmaceutical composition, a food or drink, or a feed which has an effect on the prevention and/or treatment of an intestinal disease such as ulcerative colitis, Crohn's disease or irritable bowel syndrome. A preferred embodiment is the pharmaceutical composition, food or drink, or feed which contains lactoperoxidase as an active ingredient and has an effect on the prevention and/or treatment of an intestinal disease, wherein the intestinal disease is at least one disease selected from ulcerative colitis, Crohn's disease and irritable bowel syndrome. | 01-15-2009 |
20090012001 | LIPID METABOLISM-IMPROVING AGENT - The present invention relates to an agent for improving lipid metabolism, a food/drink, and a feed, containing αs-casein as an active ingredient thereof. In addition, the present invention relates to an agent for suppressing body weight gain, an agent for reducing body fat, and an agent for reducing blood lipid, containing the agent for improving lipid metabolism. | 01-08-2009 |
20090004307 | Aloe Vera Extract, Method of Producing Aloe Vera Extract, and Hyperglycemia Improving Agent - The present invention provides: an | 01-01-2009 |
20080287365 | DRUG AND METHOD FOR PROLIFERATING NATURAL KILLER CELLS - Natural Killer (NK) cells are obtained by administering a Toll-like receptor ligand such as polyinosinic-polycytidylic acid into the peritoneal cavity of an animal to which lactoferrin has been administered to proliferate NK cells in the peritoneal cavity and collecting NK cells from the peritoneal cavity. | 11-20-2008 |
20080227171 | Process For Producing Lactoperoxidase - A process for producing lactoperoxidase, including: a step (1) for bringing one or more milk materials into contact with a cation exchanger having weakly acidic groups as ion exchange groups to thereby effect adsorption treatment; a step (2) for washing the cation exchanger after the adsorption treatment; a step (3) for bringing the cation exchanger after the washing into contact with a leaching solvent to thereby obtain a leaching solution having lactoperoxidase eluted into the leaching solvent; a step (4) for concentrating the leaching solution through an ultrafiltration membrane to thereby effect precipitation in the concentrated leaching solution; and a step (5) for obtaining a lactoperoxidase solution by removing the precipitation from the concentrated leaching solution. | 09-18-2008 |